All Journals > Clinical Infectious Diseases > 15 June 2008 > Definitions of Invasive Fungal Disease

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

15 June 2008

Volume 46, Number 12
Clinical Infectious Diseases 2008;46:1813–1821
1058-4838/2008/4612-0002$15.00
DOI: 10.1086/588660
MAJOR ARTICLE

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Ben De Pauw,a

Thomas J. Walsh,a

J. Peter Donnelly,a

David A. Stevens,

John E. Edwards,

Thierry Calandra,

Peter G. Pappas,

Johan Maertens,

Olivier Lortholary,

Carol A. Kauffman,

David W. Denning,

Thomas F. Patterson,

Georg Maschmeyer,

Jacques Bille,

William E. Dismukes,

Raoul Herbrecht,

William W. Hope,

Christopher C. Kibbler,

Bart Jan Kullberg,

Kieren A. Marr,

Patricia Muñoz,

Frank C. Odds,

John R. Perfect,

Angela Restrepo,

Markus Ruhnke,

Brahm H. Segal,

Jack D. Sobel,

Tania C. Sorrell,

Claudio Viscoli,

John R. Wingard,

Theoklis Zaoutis, and

John E. Bennettb

Background.Invasive fungal diseases are important causes of morbidity and mortality. Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies. A standard set of definitions strengthens the consistency and reproducibility of such studies.

Methods.After the introduction of the original European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group definitions, advances in diagnostic technology and the recognition of areas in need of improvement led to a revision of this document. The revision process started with a meeting of participants in 2003, to decide on the process and to draft the proposal. This was followed by several rounds of consultation until a final draft was approved in 2005. This was made available for 6 months to allow public comment, and then the manuscript was prepared and approved.

Results.The revised definitions retain the original classifications of “proven,” “probable,” and “possible” invasive fungal disease, but the definition of “probable” has been expanded, whereas the scope of the category “possible” has been diminished. The category of proven invasive fungal disease can apply to any patient, regardless of whether the patient is immunocompromised, whereas the probable and possible categories are proposed for immunocompromised patients only.

Conclusions.These revised definitions of invasive fungal disease are intended to advance clinical and epidemiological research and may serve as a useful model for defining other infections in high‐risk patients.

Received 11 September 2007; accepted 20 February 2008; electronically published 5 May 2008.

Reprints or correspondence: J. Peter Donnelly, Dept. of Haematology, Radboud University Nijmegen Medical Centre, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands ().

Cited by

Laura Banov, Claudio Garanata, Carlo Dufour, Alberto Garaventa, Eddi Di Marco, Ilaria Caviglia, Cristina Moroni, Elio Castagnola. (2009) Pneumonia due to Mycoplasma pneumoniae in granulocytopenic children with cancer. Pediatric Blood & Cancer 53:2, 240-242
Online publication date: 1-Sep-2009.
CrossRef
Ronen Ben-Ami, Russell E Lewis, Dimitrios P Kontoyiannis. (2009) Invasive mould infections in the setting of hematopoietic cell transplantation: current trends and new challenges. Current Opinion in Infectious Diseases 22:4, 376-384
Online publication date: 1-Sep-2009.
CrossRef
Nikolaos G Almyroudis, Brahm H Segal. (2009) Prevention and treatment of invasive fungal diseases in neutropenic patients. Current Opinion in Infectious Diseases 22:4, 385-393
Online publication date: 1-Sep-2009.
CrossRef
Sheng‐Yuan Ruan, Jung‐Yien Chien, and Po‐Ren Hsueh. (2009) Invasive Trichosporonosis Caused by Trichosporon asahii and Other Unusual Trichosporon Species at a Medical Center in Taiwan. Clinical Infectious Diseases 49:1, e11-e17
Online publication date: 1-Jul-2009.
C. H. Heath, M. A. Slavin, T. C. Sorrell, R. Handke, A. Harun, M. Phillips, Q. Nguyen, L. Delhaes, D. Ellis, W. Meyer, S. C. A. Chen, . (2009) Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clinical Microbiology and Infection
Online publication date: 1-Jul-2009.
CrossRef
Koki Ueda, Yasuhito Nannya, Keiki Kumano, Akira Hangaishi, Tsuyoshi Takahashi, Yoichi Imai, Mineo Kurokawa. (2009) Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders. International Journal of Hematology 89:5, 592-599
Online publication date: 1-Jul-2009.
CrossRef
R Olsson, J-E Juto, J Mattsson. (2009) Ethmoiditis-associated apex syndrome may result in temporary blindness after allo-SCT. Bone Marrow Transplantation
Online publication date: 4-Jun-2009.
CrossRef
P. E. Verweij, J. Maertens. (2009) Moulds: diagnosis and treatment. Journal of Antimicrobial Chemotherapy 63:Supplement 1, i31-i35
Online publication date: 1-Jun-2009.
CrossRef
S. S. Weigt, R. M. Elashoff, C. Huang, A. Ardehali, A. L. Gregson, B. Kubak, M. C. Fishbein, R. Saggar, M. P. Keane, R. Saggar, J. P. Lynch III, D. A. Zisman, D. J. Ross, J. A. Belperio. (2009) Aspergillus Colonization of the Lung Allograft Is a Risk Factor for Bronchiolitis Obliterans Syndrome. American Journal of Transplantation
Online publication date: 1-Jun-2009.
CrossRef
M. Ellis, B. Al-Ramadi, R. Bernsen, J. Kristensen, H. Alizadeh, U. Hedstrom. (2009) Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. Journal of Medical Microbiology 58:5, 606-615
Online publication date: 1-Jun-2009.
CrossRef
J. E. Bennett. (2009) Management of mycoses in neutropenic patients: a brief history, 1960-2008. Journal of Antimicrobial Chemotherapy 63:Supplement 1, i23-i26
Online publication date: 1-Jun-2009.
CrossRef
Robin K. Avery. (2009) Aspergillosis in hematopoietic stem cell transplant recipients: Risk factors, prophylaxis, and treatment. Current Infectious Disease Reports 11:3, 223-228
Online publication date: 1-Jun-2009.
CrossRef
Johan Maertens, Wouter Meersseman, Pascal Van Bleyenbergh. (2009) New therapies for fungal pneumonia. Current Opinion in Infectious Diseases 22:2, 183-190
Online publication date: 1-May-2009.
CrossRef
P Zhang, A Song, Z Wang, S Feng, L Qiu, M Han. (2009) Hematopoietic SCT in patients with a history of invasive fungal infection. Bone Marrow Transplantation 43:7, 533-537
Online publication date: 1-May-2009.
CrossRef
Rishi Desai, Lawrence A. Ross, Jill A. Hoffman. (2009) The Role of Bronchoalveolar Lavage Galactomannan in the Diagnosis of Pediatric Invasive Aspergillosis. The Pediatric Infectious Disease Journal 28:4, 283-286
Online publication date: 1-May-2009.
CrossRef
H Hebart, L Klingspor, T Klingebiel, J Loeffler, J Tollemar, P Ljungman, H Wandt, K Schaefer-Eckart, H J Dornbusch, C Meisner, C Engel, N Stenger, T Mayer, O Ringden, H Einsele. (2009) A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. Bone Marrow Transplantation 43:7, 553-561
Online publication date: 1-May-2009.
CrossRef
E Hardak, M Yigla, I Avivi, O Fruchter, H Sprecher, I Oren. (2009) Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome. Bone Marrow Transplantation
Online publication date: 23-Apr-2009.
CrossRef
Ronen Ben‐Ami, Russell E. Lewis, Issam I. Raad, and Dimitrios P. Kontoyiannis. (2009) Phaeohyphomycosis in a Tertiary Care Cancer Center. Clinical Infectious Diseases 48:8, 1033-1041
Online publication date: 15-Apr-2009.
Daniel R. Kaul, James Riddell. (2009) Approach to the immunocompromised patient with pulmonary nodules. Current Fungal Infection Reports 3:1, 45-54
Online publication date: 1-Apr-2009.
CrossRef
C. León, F. Álvarez-Lerma, S. Ruiz-Santana, M. Á. León, J. Nolla, R. Jordá, P. Saavedra, M. Palomar, . (2009) Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. European Journal of Clinical Microbiology & Infectious Diseases 28:3, 233-242
Online publication date: 1-Apr-2009.
CrossRef
Alison G. Freifeld. (2009) Real-time polymerase chain reaction testing for early detection of invasive aspergillosis in patients with febrile neutropenia. Current Fungal Infection Reports 3:1, 1-3
Online publication date: 1-Apr-2009.
CrossRef
G. Montenegro, S. Sanchez Puch, V. M. Jewtuchowicz, M. V. Pinoni, S. Relloso, E. Temporitti, C. A. Iovannitti, M. T. Mujica. (2009) Phenotypic and genotypic characterization of Aspergillus lentulus and Aspergillus fumigatus isolates in a patient with probable invasive aspergillosis. Journal of Medical Microbiology 58:3, 391-395
Online publication date: 1-Apr-2009.
CrossRef
Christina E. Barkauskas, John R. Perfect. (2009) Candida pneumonia: What we know and what we don’t. Current Fungal Infection Reports 3:1, 21-31
Online publication date: 1-Apr-2009.
CrossRef
Thomas R. Rogers, Susanna Frost. (2009) Newer antifungal agents for invasive fungal infections in patients with haematological malignancy. British Journal of Haematology 144:5, 629-641
Online publication date: 1-Apr-2009.
CrossRef
G. Maschmeyer, M. Sandherr. (2009) Infektionen in der Hämatologie und Onkologie. Der Internist 50:2, 187-202
Online publication date: 1-Mar-2009.
CrossRef
Fabio Forghieri, Giulio Rossi, Leonardo Potenza, Monica Morselli, Patrizia Barozzi, Daniela Vallerini, Massimino Messino, Fabio Rumpianesi, Monica Pecorari, Giuseppe Torelli, Mario Luppi. (2009) Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. American Journal of Hematology NA-NA
Online publication date: 1-Feb-2009.
CrossRef
Shigenori Kusuki, Yoshiko Hashii, Hisao Yoshida, Sachiko Takizawa, Emiko Sato, Sadao Tokimasa, Hideaki Ohta, Keiichi Ozono. (2009) Antifungal prophylaxis with micafungin in patients treated for childhood cancer. Pediatric Blood & Cancer n/a-n/a
Online publication date: 1-Feb-2009.
CrossRef
Kyoung-Ho Song, Shinwon Lee, Hee-Chang Jang, Jae Hyun Jeon, Wan Beom Park, Kyoung Un Park, Sang-Won Park, Myoung-don Oh, Kang Won Choe. (2009) Diagnostic Usefulness of Galactomannan Assay for Invasive Aspergillosis. Infection and Chemotherapy 41:2, 82
Online publication date: 1-Feb-2009.
CrossRef
J. Peter Donnelly, Rosemary A. Barnes, Jurgen Loeffler. (2009) Challenges and progress in setting a standard for PCR for invasive aspergillosis. Current Fungal Infection Reports 2:4, 232-236
Online publication date: 1-Jan-2009.
CrossRef
Lennert Slobbe, Suzanne Polinder, Jeanette K. Doorduijn, Pieternella J. Lugtenburg, Abdelilah el Barzouhi, Ewout W. Steyerberg, and Bart J. A. Rijnders. (2008) Outcome and Medical Costs of Patients with Invasive Aspergillosis and Acute Myelogenous Leukemia–Myelodysplastic Syndrome Treated with Intensive Chemotherapy: An Observational Study. Clinical Infectious Diseases 47:12, 1507-1512
Online publication date: 15-Dec-2008.
Johan Maertens, Griet Huysmans, Koen Theunissen. (2008) Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients. Current Infectious Disease Reports 10:6, 459-465
Online publication date: 1-Dec-2008.
CrossRef
Valerio Del Bono, Małgorzata Mikulska, Claudio Viscoli. (2008) Invasive aspergillosis: diagnosis, prophylaxis and treatment. Current Opinion in Hematology 15:6, 586-593
Online publication date: 1-Dec-2008.
CrossRef
Shigeru Kohno. (2008) Editorial Commentary: High Mortality in Invasive Aspergillosis: What We Need to Know for Determination of Poor Prognosis and Next Countermeasures. Clinical Infectious Diseases 47:9, 1185-1187
Online publication date: 1-Nov-2008.
Johan Maertens, Jenny Bryan. (2008) Recent progress in the management of invasive fungal infections in hematopoietic stem cell transplant recipients. Future Microbiology 3:5, 493-496
Online publication date: 1-Nov-2008.
CrossRef
Brahm H. Segal, Raoul Herbrecht, David A. Stevens, Luis Ostrosky‐Zeichner, Jack Sobel, Claudio Viscoli, Thomas J. Walsh, Johan Maertens, Thomas F. Patterson, John R. Perfect, Bertrand Dupont, John R. Wingard, Thierry Calandra, Carol A. Kauffman, John R. Graybill, Lindsey R. Baden, Peter G. Pappas, John E. Bennett, Dimitrios P. Kontoyiannis, Catherine Cordonnier, Maria Anna Viviani, Jacques Bille, Nikolaos G. Almyroudis, L. Joseph Wheat, Wolfgang Graninger, Eric J. Bow, Steven M. Holland, Bart‐Jan Kullberg, William E. Dismukes, and Ben E. De Pauw. (2008) Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria. Clinical Infectious Diseases 47:5, 674-683
Online publication date: 1-Sep-2008.
Maria J G T Rüping, Jörg J Vehreschild, Oliver A Cornely. (2008) Patients at High Risk of Invasive Fungal Infections. Drugs 68:14, 1941-1962
Online publication date: 1-Feb-2008.
CrossRef
  • B.d.P. and T.J.W. served as cochairs and J.P.D. served as secretary for the EORTC/MSG Consensus Group.

  • Author affiliations are listed at the end of the text.

Close Popup